Skip to navigation Skip to content

Growth hormone deficiency – childhood onset or late onset Program in Pharmaceutical Benefits Scheme (PBS) 012-18112104

Expand/Collapse all sectionsExpand all


This document outlines details of PBS-subsidised somatropin for patients with childhood onset or late onset of severe growth hormone deficiency, previously known as ‘adult growth hormone deficiency (AGHR)’.

Severe growth hormone deficiency and listing dates

Severe growth hormone deficiency is a condition where the body is unable to produce enough hormone which impairs the growth and development of adults.

Listing date:

  • somatropin - 1 December 2018

See Written Authority Required Drugs for more information.

Treatment specifics

Somatropin is not PBS-subsidised for patients with Prader-Willi Syndrome aged 18 years or older without a documented childhood-onset growth hormone deficiency.

Enquiries

Transfer enquiries about prescription arrangements to the PBS Complex Drugs Programs team and choose the option relevant to the condition treated.

The Resources page contains links to application forms, contact details, item and restriction codes, the PBS schedule and the Services Australia website.

Online Pharmaceutical Benefits Scheme (PBS) Authorities System (OPA System)

Process telephone Authority approval application

Processing and National Demand Allocation (PaNDA)

Processing written authority approval request

Processing Complex Authority Required Listings

Written Authority Required Drugs